Pharmcore Inc. dba Hallandale Pharmacy
Form 483 issued June 13, 2025 · Fort Lauderdale, Florida
- Inspection
- Jun 3 – Jun 13, 2025
- Investigator
- Logan T. Williams
- Observations
- 2
- Pages
- 4
- FEI number
- 3014480778
In short: On June 13, 2025, FDA issued a Form 483 with 2 observations to Pharmcore Inc. dba Hallandale Pharmacy in Fort Lauderdale, Florida (FEI 3014480778) after an inspection that ran Jun 3 – Jun 13, 2025. The investigator was Logan T. Williams.
What FDA observed
Preview: the opening words of each observation- 01FDCA 501(a)(2)(A)
Materials were exposed to lower than…
- 02FDCA 501(a)(2)(A)
Smoke studies were inadequately…
This inspection in context
Logan T. Williams
32 documents · 2020–2026
Cites 211.113 (control of microbiological contamination) more than any other section. Most of their documents are for sites in Kentucky.
The firmPharmcore Inc. dba Hallandale Pharmacy history
All 5 documents on file for this site, in date order, with what was cited at each inspection.
Similar 483sMore form 483s
Browse other documents of this type.
Questions about this 483
What did FDA find at Pharmcore Inc. dba Hallandale Pharmacy?
FDA listed 2 observations on this Form 483. The opening words of each observation are shown on this page.
Who inspected Pharmcore Inc. dba Hallandale Pharmacy?
Logan T. Williams is named on this Form 483, for the inspection of Jun 3 – Jun 13, 2025. Each investigator has a profile showing what they cite most.
When was Pharmcore Inc. dba Hallandale Pharmacy inspected by FDA?
The inspection ran Jun 3 – Jun 13, 2025, and the Form 483 is dated June 13, 2025.
How do I get the full Form 483 for Pharmcore Inc. dba Hallandale Pharmacy?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.